RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

The Omnitest plus blood glucose monitor consist of a sensor system for measuring blood glucose in capillary blood. The Omnitest® plus system provides a quick and easy way to measure the blood ...

Checking the blood glucose with the BGStarTM couldn’t be simpler. Insert a test strip with the contact bars facing up. Use the lancing device to obtain a blood drop then touch the end of the ...

The protocol was approved by the institutional review boards of Massachusetts Institute of Technology and Beth Israel Deaconess Medical ... Non-invasive blood glucose monitoring.

Glucotrack (Nasdaq:GCTK) announced today that it completed the first-in-human clinical study of its continuous blood glucose ...

Glucotrack (GCTK) reports successful completion of first human clinical study for continuous blood glucose monitoring, shares ...